Abstract
In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.
Cite
CITATION STYLE
APA
Beresford, M. W., Primhak, R., Subhedar, N. V., & Shaw, N. J. (2002). Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease. Archives of Disease in Childhood: Fetal and Neonatal Edition, 87(1). https://doi.org/10.1136/fn.87.1.f62
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free